홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ANTX
#3983
AN2 Therapeutics, Inc. Common Stock
3.2
6
USD
+9.40%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+9.40%
월간 변동
-32.37%
6달 변화
+165.04%
년간 변동율
+160.80%
이전 종가
2.9
8
Open
3.2
6
Bid
Ask
Low
3.2
6
High
3.2
6
양
14
마켓
주식
헬스케어
ANTX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
30.1 M
30.18 M
27.33 M
27.4 M
35.94 M
—
Valuation ratios
Enterprise value
20.19 M
21.05 M
10.75 M
16.8 M
21.03 M
69.63 M
Price to earnings ratio
-0.8
-0.9
-0.85
-1.13
-0.98
-3.87
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-0.84
-0.96
-0.89
-1.28
-1.15
-4.29
Price to book ratio
0.5
0.12
0.1
0.13
0.65
1
EBITDA 비율에 대한 기업 가치
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.08
-0.13
-0.09
-0.14
-0.14
-0.5
Return on equity %
-0.09
-0.15
-0.09
-0.15
-0.16
-0.56
Return on invested capital %
-684.69
—
—
—
-205.13
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.07
9.29
11.67
12.52
6.87
40.36
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.18
-0.35
-0.25
-0.21
-0.17
-0.99
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.8
2.23
2.09
2.05
1.92
8.28
Net current asset value per share
2.89
2.31
2.24
2.11
1.98
8.65
Tangible book value per share
2.74
2.44
2.28
1.99
1.76
8.47
Working capital per share
2.6
2.07
2.05
1.95
1.7
7.75
Book value per share
2.74
2.44
2.28
1.99
1.76
8.47
뉴스
AN2 Therapeutics Stock Cools Off After 90% Rally - AN2 Therapeutics (NASDAQ:ANTX)
AN2 Therapeutics Stock Jumps 90% Monday: What's Driving The Action? - AN2 Therapeutics (NASDAQ:ANTX)
AN2 Therapeutics raises $40M in private placement
AN2 테라퓨틱스, PV/n에페트라보롤 2상 임상시험 계획
AN2 Therapeutics plans phase 2 trial of epetraborole in PV
AN2 테라퓨틱스, Sarah Williams 회계 책임자로 임명
AN2 Therapeutics appoints Sarah Williams as principal accounting officer
FDA clears IND for epetraborole trial in mycobacterium abscessus
AN2 Therapeutics (ANTX) Upgraded to Buy: What Does It Mean for the Stock?
Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year?
AN2 테라퓨틱스(ANTX) CFO Day, 8,883달러 상당 주식 매도
An2 therapeutics (ANTX): cfo Day sells $8883 in shares